NCT02095288View on ClinicalTrials.gov

Lipidomics Screening of Anti-inflammatory Drugs and Drug Candidates in Vitro - Part A

Active, not recruitingOBSERVATIONAL
Enrollment

30

Participants

Timeline

Start Date

November 30, 2013

Primary Completion Date

June 30, 2027

Study Completion Date

July 31, 2029

Conditions
Healthy
Interventions
PROCEDURE

Blood draw

This is a single blood donation, no drugs or devices administered

Trial Locations (1)

19104

The Clinical Translational Research Center (CTRC) at the Hospital of the University of Pennsylvania, Philadelphia

All Listed Sponsors
collaborator

Eli Lilly and Company

INDUSTRY

lead

University of Pennsylvania

OTHER

NCT02095288 - Lipidomics Screening of Anti-inflammatory Drugs and Drug Candidates in Vitro - Part A | Biotech Hunter | Biotech Hunter